MELISSA CETONE: Open Payments
NPI 1528231644 · GERMANTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,774 in 195 payments from 13 companies in 2025. Trend: 2023 $2,263 · 2024 $2,778 · 2025 $2,774
Food & beverage: $2,770Education: $4
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $431 |
| Janssen Pharmaceuticals, Inc | 24 | $382 |
| Teva Pharmaceuticals USA, Inc. | 23 | $353 |
| E.R. Squibb & Sons, L.L.C. | 46 | $338 |
| Neurocrine BioSciences, Inc. | 13 | $300 |
| Lundbeck LLC | 15 | $217 |
| Alkermes, Inc. | 13 | $215 |
| ABBVIE INC. | 17 | $178 |
| Vanda Pharmaceuticals Inc. | 9 | $158 |
| Axsome Therapeutics, Inc. | 3 | $71 |
Products named: REXULTI, INVEGA SUSTENNA, COBENFY, INGREZZA, UZEDY, VRAYLAR, ARISTADA, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
